Tci Wealth Advisors, Inc. Crispr Therapeutics Ag Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$41.0 - $56.12 $4,100 - $5,612	100 New	100 $4,000
Q2 2022 Jul 19, 2022	SELL	$43.23 - $73.83 $345 - $590	-8 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$110.2 - $156.64 $1,322 - $1,879	-12 Reduced 60.0%	8 $1,000
Q2 2021 Aug 02, 2021	BUY	$100.84 - $161.89 $504 - $809	5 Added 33.33%	20 $3,000
Q1 2020 Apr 14, 2020	BUY	$33.68 - $62.53 $336 - $625	10 Added 200.0%	15 $1,000
Q2 2019 Jul 23, 2019	BUY	$35.45 - $48.2 $177 - $241	5 New	5 $0

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.23B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.